Taken together, these observations support the already proposed hypothesis that NEK1 variants may confer a significant susceptibility to ALS, even though they may be not sufficient per se for disease development, possibly acting as a phenotypic modifier (Nguyen et al., 2018; Lattante et al., 2021). The gene discussed is NEK1; the disease is amyotrophic lateral sclerosis.